A potential Sycamore buyout sounded like good news--until analysts revealed the brutal reality behind the deal.

Walgreens shares fell more than 5% Friday as details about a potential sale emerged and one analyst team said the stock had ...

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...

Boots’ prospective buyer Sycamore Partners is planning to separate the UK retail pharmacy business from its US and healthcare ...

A rumored private equity buyout of Walgreens could lead the company to be split up, according to media reports. | A rumored ...

Shares of Walgreens Boots Alliance (NASDAQ: WBA) rose on Thursday, up as much as 7.3% before settling into a 2.2% gain by ...

PE firm Sycamore Partners reportedly plans to split Walgreens Boots Alliance into three independent businesses if it successfully acquires the drugstore chain.

What the telehealth prescribers can’t do, the compounders are. A major drug compounder association, the Outsourcing Facilities Association, along with member North American Custom Laboratories, LLC, ...

The private-equity suitor is planning on splitting up Walgreens' U.S. and U.K. pharmacy businesses, as well as its specialty ...